References
- Steineck G, Schmidt H, Alevronta E, et al. Toward restored bowel health in rectal cancer survivors. Semin Radiat Oncol. 2016;26:236–250.
- Alevronta E, Lind H, Al-Abany M, et al. Dose-response relationships for an atomized symptom of fecal incontinence after gynecological radiotherapy. Acta Oncol. 2013;52:719–726.
- Kuku S, Fragkos C, McCormack M, et al. Radiation-induced bowel injury: the impact of radiotherapy on survivorship after treatment for gynaecological cancers. Br J Cancer. 2013;109:1504–1512.
- Steineck G, Skokic V, Sjoberg F, et al. Identifying radiation-induced survivorship syndromes affecting bowel health in a cohort of gynecological cancer survivors. PLoS One. 2017;12:e0171461.
- Alsadius D, Hedelin M, Johansson KA, et al. Tobacco smoking and long-lasting symptoms from the bowel and the anal-sphincter region after radiotherapy for prostate cancer. Radiother Oncol. 2011;101:495–501.
- Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. JCO. 2002;20:3651–3657.
- van der Voet JC, Keus RB, Hart AA, et al. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42:247–255.
- Oh JH, Thor M, Olsson C, et al. A factor analysis approach for clustering patient reported outcomes. Methods Inf Med. 2016;55:431–439.
- Ferreira MR, Muls A, Dearnaley DP, et al. Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist. Lancet Oncol. 2014;15:e139–e147.
- Da Silva GM, Berho M, Wexner SD, et al. Histologic analysis of the irradiated anal sphincter. Dis Colon Rectum. 2003;46:1492–1497.
- Straub JM, New J, Hamilton CD, et al. Radiation-induced fibrosis: mechanisms and implications for therapy. J Cancer Res Clin Oncol. 2015;141:1985–1994.
- NIH. National Cancer Institute: common terminology criteria for adverse events v4.0. Washington, D.C.: NCI, NIH, DHHS; 2009.
- Dunberger G, Lind H, Steineck G, et al. Self-reported symptoms of faecal incontinence among long-term gynaecological cancer survivors and population-based controls. Eur J Cancer. 2010;46:606–615.
- Steineck G, Hunt H, Adolfsson J. A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods. Acta Oncol. 2006;45:421–429.
- Steineck G, Bergmark K, Henningsohn L, et al. Symptom documentation in cancer survivors as a basis for therapy modifications. Acta Oncol. 2002;41:244–252.
- Mansson A, Henningsohn L, Steineck G, et al. Neutral third party versus treating institution for evaluating quality of life after radical cystectomy. Eur Urol. 2004;46:195–199.
- Santen S, Wang Y, Laschke MW, et al. Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion. Int J Colorectal Dis. 2010;25:1063–1070.
- Mihaescu A, Santen S, Jeppsson B, et al. p38 Mitogen-activated protein kinase signalling regulates vascular inflammation and epithelial barrier dysfunction in an experimental model of radiation-induced colitis. Br J Surg. 2010;97:226–234.
- Yarnold J, Brotons MC. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97:149–161.
- Fushimi H, Kubo M, Inoue T, et al. Peripheral vascular reactions to smoking-profound vasoconstriction by atherosclerosis. Diabetes Res Clin Pract. 1998;42:29–34.
- Verschuere S, De Smet R, Allais L, et al. The effect of smoking on intestinal inflammation: what can be learned from animal models? J Crohns Colitis. 2012;6:1–12.
- Taylor S, Demeyin W, Muls A, et al. Improving the well-being of men by evaluating and addressing the gastrointestinal late effects (EAGLE) of radical treatment for prostate cancer: study protocol for a mixed-method implementation project. BMJ Open. 2016;6:e011773.
- Touchefeu Y, Montassier E, Nieman K, et al. Systematic review: the role of the gut microbiota in chemotherapy- or radiation-induced gastrointestinal mucositis – current evidence and potential clinical applications. Aliment Pharmacol Ther. 2014;40:409–421.